(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
The most effective method to Guarantee Scholastic Honesty in Web-based Degrees - 2One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
- 3I thought I knew the night sky, but what I saw from the Canary Islands left me speechless
- 4Picking Your Next SUV: 4 Brands Offering Execution, Solace, and Wellbeing
- 57 Well known Vacation spots In The US
- Figure out How to Pick a Crematorium: Key Contemplations.
- How did this 20-light-year-wide 'Diamond Ring' form in space? Maybe a cosmic bubble burst
- Which sandwich do you find totally delectable? !
- Vote in favor of the Top Vegetable for Senior
- Why this Tennessee special election has the 'whole world' watching
- Audits of 6 Specialty Mixed drinks
- A NASA spacecraft orbiting Mars may be dead
- People Are Sharing The One Picture They Can't See Without Laughing, And It's The Comedy Spiral You Need Today
- Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
